Pharmena S.A. (WSE:PHR)

Market Cap	36.75M
Revenue (ttm)	1.27M
Net Income (ttm)	-2.20M
Shares Out	11.14M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	0.85 (32.08%)
Ex-Dividend Date	n/a

Volume	53,728
Average Volume	16,366
Open	2.900
Previous Close	2.650
Day's Range	2.900 - 3.300
52-Week Range	2.500 - 4.790
Beta	0.55
RSI	63.87
Earnings Date	Mar 31, 2026

About Pharmena

Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including face, hair, and body care products, as well as dietary supplement. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PHR